We developed a computer-controlled intravenous methamphetamine (METH) administration procedure (dynamic infusion), which enables us to compensate for an important pharmacokinetic difference between ...

WESTMINSTER, Colo.--(BUSINESS WIRE)--Surefire Medical, Inc. today announced that the company’s new Precision targeted delivery infusion system, for direct-to-tumor embolization procedures, has ...

Transplantation of hematopoietic stem cells (HSCs) has been successfully developed as a part of treatment protocols for a large number of clinical indications, and cryopreservation of both autologous ...

Get Access To Every Broadway Story Unlock access to every one of the hundreds of articles published daily on BroadwayWorld by logging in with one click. Written in a user-friendly format and ...

A multidisciplinary team with representatives from the departments of medicine, critical care, nursing, health care information systems (HIS), and pharmacy was formed to address the feasibility of ...

At the 2025 European Association for the Study of Diabetes (EASD) meeting in Vienna, investigators reported one-year outcomes from FORWARD, a pivotal study of zimislecel (VX-880), an allogeneic, stem ...

TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, is ...

Normal pressure hydrocephalus (NPH) is a condition in which a clear, colourless fluid called cerebrospinal fluid (or CSF) accumulates around the brain and spinal cord. Symptoms include problems with ...

WESTMINSTER, Colo., Sept. 5, 2012 /PRNewswire/ -- European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures.